Paclitaxel quantification in mouse plasma and tissues containing liposome-entrapped paclitaxel by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetics study

被引:59
作者
Guo, W [1 ]
Johnson, JL [1 ]
Khan, S [1 ]
Ahmad, A [1 ]
Ahmad, I [1 ]
机构
[1] NeoPharm Inc, Res & Dev, Pharmacokinet Safety & Efficacy Dept, Waukegan, IL 60085 USA
关键词
paclitaxel; docetaxel; liposome; bioanalysis; LC-MS/MS;
D O I
10.1016/j.ab.2004.09.046
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A liquid chromatography-tandem mass spectrometry assay to quantify total paclitaxel in mouse plasma and tissue homogenates containing paclitaxel, Taxol, or liposome-entrapped paclitaxel-easy to use (LEP-ETU) was developed and validated. Docetaxel was used as the internal standard (IS). Liquid-liquid extraction with tert-butyl methyl ether was used for plasma sample preparation, and a one-step protein precipitation with acetonitrile containing 0.1% acetic acid was developed for tissue homogenates. Paclitaxel and IS are separated on a 50 x 2.1-mm C18 column and quantified using a triple-quadrupole mass spectrometer operating in positive ion electrospray multiple reaction monitoring mode, with a total run time of 3.5 min. The peak area of the m/z 854.4 --> 286.2 transition of paclitaxel is measured versus that of the m/z 808.5 --> 527.5 transition of IS to generate the standard curve. In plasma, the linear range is 0.2-500 ng/mL and could be extended by dilution to 100,000 ng/mL with acceptable precision and accuracy (less than or equal to15%). The lower limit of quantification is 0.5 ng/mL in tissue homogenates (10 ng/g tissue), and the standard curve is linear up to 1000 ng/mL, with precision and accuracy less than or equal to15%. This assay was used to support a pharmacokinetics and tissue distribution study of LEP-ETU ill mice. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 24 条
  • [1] Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma
    Alexander, MS
    Kiser, MM
    Culley, T
    Kern, JR
    Dolan, JW
    McChesney, JD
    Zygmunt, J
    Bannister, SJ
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 785 (02): : 253 - 261
  • [2] ALI S, 2003, P AM ASSOC CANC RES, P44
  • [3] Auzenne E, 2002, CLIN CANCER RES, V8, P573
  • [4] Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry
    Basileo, G
    Breda, M
    Fonte, G
    Pisano, R
    James, CA
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 32 (4-5) : 591 - 600
  • [5] From conventional to stealth liposomes a new frontier in cancer chemotherapy
    Cattel, L
    Ceruti, M
    Dosio, F
    [J]. TUMORI, 2003, 89 (03) : 237 - 249
  • [6] Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel
    Constantinides, PP
    Lambert, KJ
    Tustian, AK
    Schneider, B
    Lalji, S
    Ma, WW
    Wentzel, B
    Kessler, D
    Worah, D
    Quay, SC
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (02) : 175 - 182
  • [7] *FOOD DRUG ADM CTR, BIOAN METH VAL
  • [8] NONLINEAR PHARMACOKINETICS AND METABOLISM OF PACLITAXEL AND ITS PHARMACOKINETIC/PHARMACODYNAMIC RELATIONSHIPS IN HUMANS
    GIANNI, L
    KEARNS, CM
    GIANI, A
    CAPRI, G
    VIGANO, L
    LOCATELLI, A
    BONADONNA, G
    EGORIN, MJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) : 180 - 190
  • [9] Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography-mass spectrometry
    Guo, P
    Ma, JG
    Li, SL
    Gallo, JM
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 798 (01): : 79 - 86
  • [10] Uposomally targeted cytotoxic drugs for the treatment of cancer
    Harrington, KJ
    Syrigos, KN
    Vile, RG
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (12) : 1573 - 1600